Calumet Specialty Products Stock Investor Sentiment
CLMT Stock | USD 13.04 0.42 3.12% |
Slightly above 68% of Calumet Specialty's investor base is looking to short. The current sentiment regarding investing in Calumet Specialty Products stock implies that many traders are alarmed. Calumet Specialty's investing sentiment can be driven by a variety of factors including economic data, Calumet Specialty's earnings reports, geopolitical events, and overall market trends.
Calumet |
Calumet Specialty Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Calumet Specialty can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Calumet Specialty Maximum Pain Price Across May 16th 2025 Option Contracts
Calumet Specialty's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Calumet Specialty close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Calumet Specialty's options.
Far too much social signal, news, headlines, and media speculation about Calumet Specialty that are available to investors today. That information is available publicly through Calumet media outlets and privately through word of mouth or via Calumet internal channels. However, regardless of the origin, that massive amount of Calumet data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Calumet Specialty news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Calumet Specialty relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Calumet Specialty's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Calumet Specialty alpha.
Calumet Specialty Performance against Dow Jones
Price Growth (%) |
Timeline |
1 | Disposition of 8921 shares by Straumins Jennifer of Calumet Specialty subject to Rule 16b-3 | 12/04/2024 |
2 | Calumet Specialty Products Partners Shares Gap Up Following Analyst Upgrade | 01/15/2025 |
3 | Calumet Inc Shares Up 4.86 percent on Jan 29 | 01/29/2025 |
4 | Calumet Specialty Products Partners Trading Down 7.6 percent Should You Sell | 02/05/2025 |
5 | Calumet Inc Trading 16.72 percent Higher on Feb 12 | 02/12/2025 |
6 | Calumet Specialty Products Partners Shares Down 5.9 percent Heres Why | 02/13/2025 |
7 | Calumet, Inc. to Release Fourth Quarter and Fiscal Year 2024 Earnings on February 28, 2025 | 02/14/2025 |
8 | Calumet to Attend Raymond James Conference | 02/19/2025 |
9 | Calumet Inc to Attend Raymond James Institutional Investors Conference | 02/20/2025 |
10 | Acquisition by David Lunin of 37463 shares of Calumet Specialty subject to Rule 16b-3 | 02/25/2025 |
11 | Wasserstein Debt Opportunities Management, L.P. Increases Stake in Calumet Inc. | 02/26/2025 |
12 | Calumet Announces Sale of Assets Related to Industrial Portion o | 02/28/2025 |
13 | Calumet Inc Shares Down 2.89 percent on Mar 3 | 03/03/2025 |
Additional Tools for Calumet Stock Analysis
When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.